AbbVie, Eli Lilly quit UK's voluntary drug pricing agreement, sending 'warning signal' to UK government
Major pharmas Eli Lilly and AbbVie have exited the UK National Health Service’s voluntary medicine pricing agreement, citing unjustifiable revenue clawbacks,
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.